Clinical implications of hepatogenous diabetes in liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 6, 2002, Pages 677-681

  Holstein, A ^a   Hinze, S ^a   Thiessen E ^a   Plaschke, A ^a   Egberts, E H ^a  

^a KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Diabetes; Hepatogenous diabetes; Liver cirrhosis; Prognosis

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROGNOSIS; AGED; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED; MUSCLE ATROPHY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; MUSCULAR ATROPHY; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0036019526     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02755.x     Document Type: Article

References (32)

1. Diabetes bei lebererkrankungen
2. Estimate of prevalence of glucose intolerance in chronic liver disease. Degree of agreement among some diagnostic criteria
3. Alterations of glucose metabolism in chronic liver disease
4. Long-term survival in patients with hereditary hemochromatosis
5. Glykosurie und diabetes durch experimentelle insulte und krankheiten der leber
6. Liver disease and diabetes mellitus
7. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients
8. Mechanism of insulin resistance in human liver cirrhosis
9. Hepatogenous diabetes. Pathophysiology, therapeutic options and prognosis
10. Mechanism of insulin resistance associated with liver cirrhosis
11. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
12. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population
13. Liver cirrhosis and diabetes mellitus
14. HCV and diabetes mellitus: Evidence for a negative association
15. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
16. Reproducibility of oral glucose tolerance tests with three different loads
17. The reproducibility of the oral glucose tolerance test over long (5 years) and short periods (1 week)
18. Genetics of type2A-and type2B diabetes mellitus
19. Diabetes mellitus in patients with liver cirrhosis
20. Cardiovascular disease in cirrhosis: A point-prevalence study in relation to glucose tolerance
21. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
22. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
23. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
24. Prognostic value of arterial pressure, endogenous vasoactive systems and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
25. Prognostic significance of diabetes in patients with cirrhosis
26. Failure of glucagon to stimulate glycogenolysis in well-nourished patients with mild cirrhosis
27. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation
28. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis
29. Guidelines of GASL for nutrition in liver diseases and liver transplantation
30. 1 in cirrhosis of the liver
31. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis